Effective therapeutics are urgently needed to counter infection and improve outcomes for
patients suffering from COVID-19 and to combat this pandemic. Manipulation of epigenetic …

Secondary Streptococcus pneumoniae infection is a significant cause of morbidity and mortality
during influenza epidemics and pandemics. Multiple pathogenic mechanisms, such as …

SARS-CoV-2, the virus that causes COVID-19, has given rise to one of the largest pandemics,
affecting millions worldwide. High neutrophil-to-lymphocyte ratios have been identified as …

Introduction: Respiratory syncytial virus (RSV) infection is responsible for one-third of deaths
of acute lower respiratory infection in children less than one-year-old. The formaldehyde-…

Chitosan is a polysaccharide capable of augmenting immune responses with a proven safety
record in animals and humans. These properties make it a potentially attractive agent for …

Background Over 43% of the world's population regularly consumes alcohol. Although not
commonly known, alcohol can have a significant impact on the respiratory environment. …

Lung conditions such as COPD, as well as risk factors such as alcohol misuse and cigarette
smoking, can exacerbate COVID-19 disease severity. Synergistically, these risk factors can …

Arboviruses are known to cause large-scale epidemics in many parts of the world. These
arthropod-borne viruses are a large group consisting of viruses from a wide range of families. …

The susceptibility to respiratory syncytial virus (RSV) infection in early life has been associated
with a deficient T-helper cell type 1 (Th1) response. Conversely, healthy adults generally …

Respiratory Syncytial Virus (RSV) infects almost all children under the age of one and is the
leading cause of hospitalization among infants. Despite several decades of research with …